Ticker Details
Humacyte, Inc. Common Stock
IPO Date:	November 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$218.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 3.88%
Avg Daily Range (30 D):	$0.05 | 4.76%
Avg Daily Range (90 D):	$0.05 | 4.20%

Institutional Daily Volume
Avg Daily Volume:	1.88M
Avg Daily Volume (30 D):	5.39M
Avg Daily Volume (90 D):	4.92M

Trade Size
Avg Trade Size (Sh.):	206
Avg Trade Size (Sh.) (30 D):	410
Avg Trade Size (Sh.) (90 D):	388

Institutional Trades
Total Institutional Trades:	303
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$2.37M
Avg Institutional Trade (90 D):	$1.45M
Avg Institutional Trade Volume:	.34M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.59M
Avg Closing Trade (30 D):	$2.37M
Avg Closing Trade (90 D):	$2.37M
Avg Closing Volume:	342.55K

News

Dec 22, 2025 @ 1:00 PM Humacyte Announces Publication of Long-Term Safety... Source: Na

Nov 12, 2025 @ 4:00 PM Strong Earnings and Biotech Resilience Define the ... Source: Na

Sep 18, 2025 @ 7:08 PM Russell 2000 Hits All-Time Highs: 8 Stocks Power S... Source: Piero Cingari

Aug 11, 2025 @ 11:20 AM Humacyte Posts Q2 Revenue Miss Source: Jesterai

Mar 26, 2025 @ 10:18 AM US Stocks Likely To Open Lower After 3-Day Advance... Source: Rishabh Mishra

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.11	$-.24	$.28
Diluted EPS	$-.11	$-.24	$.28
Revenue	$.75M	$.3M	$.52M
Gross Profit	$.49M	$.09M	$.37M
Net Income / Loss	$-17.51M	$-37.66M	$39.14M
Operating Income / Loss	$-24.39M	$-29.73M	$-23.18M
Cost of Revenue	$.26M	$.21M	$.15M
Net Cash Flow	$-68.54M	$-24.82M	$17.91M
PE Ratio